Nonintensive topical gentamicin treatment of patients with severe epidermolysis bullosa caused by nonsense mutations
Abstract Background Severe epidermolysis bullosa (EB) is caused by premature termination codons (PTCs) in a significant minority of the patients. Topical gentamicin has been shown to increase wound healing and can restore protein translation in patients with EB through PTC suppression. However, only...
Saved in:
Main Authors: | Ø. Sandanger (Author), M. K. Torp (Author), A. Glesaaen (Author), H. R. Nilsen (Author), J. C. Sitek (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reading through the nonsense: Gentamicin and ELX-02 as rescuing therapies for epidermolysis bullosa
by: Morgan Anderson-Crannage, et al.
Published: (2024) -
Topical gentamicin 0.1% promotes collagen 7 expression in recessive dystrophic epidermolysis bullosa
by: Rahul Mahajan, et al.
Published: (2022) -
Topical treatment of inherited epidermolysis bullosa
by: Alexey A. Kubanov, et al.
Published: (2021) -
Application of topical gentamicin ointment in the treatment of Nagashima‐type palmoplantar keratosis in children with a nonsense mutation
by: Shan Wang, et al.
Published: (2023) -
Deficient skin proteins rescue of expression in patients with epidermolysis bullosa: efficacy of gentamicin
by: Olga G. Artamonova, et al.
Published: (2024)